Press "Enter" to skip to content

Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition

0
Listen to this article
Copyright © DrugPatentWatch. Originally published at Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition

Here’s a copy of the recent talk on Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition. It’s based on the book Make Better Decisions, which distills insights gained from more than two decades of providing guidance to biopharmaceutical companies.

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at Evaluating innovative portfolios and preparing for branded, 505(b)(2), and generic competition
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

Do NOT follow this link or you will be banned from the site!